809 related articles for article (PubMed ID: 15529579)
21. [Distribution of B-lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis].
Zhang Q; Hu Y; Zhang L; Li Y; Yin H; Li J
Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):239-41. PubMed ID: 11825378
[TBL] [Abstract][Full Text] [Related]
22. [Anti-Titin-antibodies at the patients with myasthenic and non-myasthenic thymoma].
Vetshev PS; Sanadze AG; Sidnev DV; Ippolitov LI; Zhivotov VA; Ablitsov AIu
Khirurgiia (Mosk); 2007; (6):53-6. PubMed ID: 17690667
[TBL] [Abstract][Full Text] [Related]
23. Classification of myasthenia gravis based on autoantibody status.
Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Terayama Y; Suzuki N; Kuwana M
Arch Neurol; 2007 Aug; 64(8):1121-4. PubMed ID: 17698702
[TBL] [Abstract][Full Text] [Related]
24. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis].
Cui LY; Li YF; Li YH; Zhang JB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):238-40. PubMed ID: 17536276
[TBL] [Abstract][Full Text] [Related]
25. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
[TBL] [Abstract][Full Text] [Related]
26. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
27. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512
[TBL] [Abstract][Full Text] [Related]
28. Thymus and myasthenia gravis. Review of 200 cases, with experimental studies on anti-muscle antibodies and lymphocyte function.
Kano S; Takaku F; Uono M
Nihon Ketsueki Gakkai Zasshi; 1971 Aug; 34(4):420-7. PubMed ID: 5170455
[No Abstract] [Full Text] [Related]
29. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
30. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
31. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
[TBL] [Abstract][Full Text] [Related]
32. Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow.
Cikes N; Momoi MY; Williams CL; Howard FM; Hoagland HC; Whittingham S; Lennon VA
Mayo Clin Proc; 1988 May; 63(5):474-81. PubMed ID: 3283472
[TBL] [Abstract][Full Text] [Related]
33. [Anti-striational antibodies detected in a patient with late-onset myasthenia gravis suffering from severe bradycardia: a case report].
Fujita R; Matoba S; Morihata H; Inoue M
Rinsho Shinkeigaku; 2021 Aug; 61(8):543-546. PubMed ID: 34275952
[TBL] [Abstract][Full Text] [Related]
34. Increased mast cell density and microvessel density in the thymus of patients with myasthenia gravis.
Raica M; Cîmpean AM; Encică S; Scridon T; Bârsan M
Rom J Morphol Embryol; 2007; 48(1):11-6. PubMed ID: 17502945
[TBL] [Abstract][Full Text] [Related]
35. Thymoma-associated myasthenia gravis: On the search for a pathogen signature.
Cufi P; Soussan P; Truffault F; Fetouchi R; Robinet M; Fadel E; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():29-35. PubMed ID: 24440286
[TBL] [Abstract][Full Text] [Related]
36. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
Smith CI; Aarli JA; Hammarström L; Persson MA
Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
[TBL] [Abstract][Full Text] [Related]
37. Multifocal paraneoplastic cortical encephalitis associated with myasthenia gravis and thymoma.
Hammoud K; Kandimala G; Warnack W; Vernino S
Arch Neurol; 2009 Nov; 66(11):1407-9. PubMed ID: 19901174
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
[TBL] [Abstract][Full Text] [Related]
39. HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis.
Oosterhuis HJ; Feltkamp TE; van Rossum AL; van den Berg-Loonen PM; Nijenhuis LE
Ann N Y Acad Sci; 1976; 274():468-74. PubMed ID: 1085589
[TBL] [Abstract][Full Text] [Related]
40. Myasthenia gravis.
Somnier FE
Dan Med Bull; 1996 Feb; 43(1):1-10. PubMed ID: 8906977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
